Implications of DNA methylation in Parkinson’s disease

Frontiers in Molecular Neuroscience

Volumn 10, Issue , 2017, Pages

  Miranda Morales, Ernesto ^a,b   Meier, Karin ^c   Sandoval Carrillo, Ada ^b   Salas Pacheco, José ^b   Vázquez Cárdenas, Paola ^a   Arias Carrión, Oscar ^a  

^a HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^b UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^c INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

5 methylcytosine; Alpha synuclein; DNA methylation; Epigenetics; Folate; Neurodegeneration; Parkinson disease

Indexed keywords

CYTOCHROME P450 2E1; DNA METHYLTRANSFERASE; MANGANESE; TRANSCRIPTION FACTOR;

BRAIN MATURATION; BRAIN TISSUE; CARBON METABOLISM; COFFEE; DNA METHYLATION; DNA REPLICATION; ENVIRONMENTAL FACTOR; FOLIC ACID DEFICIENCY; GENE; GENE ACTIVITY; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUCIFERASE ASSAY; NERVE DEGENERATION; NUTRITION; PARKINSON DISEASE; REVIEW; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SNCA GENE;

EID: 85026668763     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2017.00225     Document Type: Review

References (158)

1. Ai, S. X., Xu, Q., Hu, Y. C., Song, C. Y., Guo, J. F., Shen, L., et al. (2014). Hypomethylation of SNCA in blood of patients with sporadic Parkinson’s disease. J. Neurol. Sci. 337, 123-128. doi: 10.1016/j.jns.2013.11.033
2. Ammal Kaidery, N., Tarannum, S., and Thomas, B. (2013). Epigenetic landscape of Parkinson’s disease: emerging role in disease mechanisms and therapeutic modalities. Neurotherapeutics 10, 698-708. doi: 10.1007/s13311-013-0211-8
3. ATSDR (2012). Toxicological Profile for Manganese. Atlanta, GA: U.S. Department of Health and Human Services.
4. Barrachina, M., and Ferrer, I. (2009). DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J. Neuropathol. Exp. Neurol. 68, 880-891. doi: 10.1097/NEN.0b013e3181af2e46
5. Behrens, M. I., Bruggemann, N., Chana, P., Venegas, P., Kagi, M., Parrao, T., et al. (2010). Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations. Mov. Disord. 25, 1929-1937. doi: 10.1002/mds.22996
6. Berman, B. P., Weisenberger, D. J., Aman, J. F., Hinoue, T., Ramjan, Z., Liu, Y., et al. (2011). Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat. Genet. 44, 40-46. doi: 10.1038/ng.969
7. Beyer, K., Domingo-Sabat, M., Santos, C., Tolosa, E., Ferrer, I., and Ariza, A. (2010). The decrease of beta-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies. Brain 133, 3724-3733. doi: 10.1093/brain/awq275
8. Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21. doi: 10.1101/gad.947102
9. Bird, A. P., and Wolffe, A. P. (1999). Methylation-induced repression-belts, braces, and chromatin. Cell 99, 451-454. doi: 10.1016/S0092-8674(00)81532-9
10. Booth, M. J., Branco, M. R., Ficz, G., Oxley, D., Krueger, F., Reik, W., et al. (2012). Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336, 934-937. doi: 10.1126/science.12 20671
11. Bowler, R. M., Beseler, C. L., Gocheva, V. V., Colledge, M., Kornblith, E. S., Julian, J. R., et al. (2016). Environmental exposure to manganese in air: associations with tremor and motor function. Sci. Total Environ. 541, 646-654. doi: 10.1016/j.scitotenv.2015.09.084
12. Bowler, R. M., Gocheva, V., Harris, M., Ngo, L., Abdelouahab, N., Wilkinson, J., et al. (2011). Prospective study on neurotoxic effects in manganese-exposed bridge construction welders. Neurotoxicology 32, 596-605. doi: 10.1016/j.neuro. 2011.06.004
13. Breen, D. P., Vuono, R., Nawarathna, U., Fisher, K., Shneerson, J. M., Reddy, A. B., et al. (2014). Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol. 71, 589-595. doi: 10.1001/jamaneurol.2014.65
14. Cai, M., Tian, J., Zhao, G. H., Luo, W., and Zhang, B. R. (2011). Study of methylation levels of parkin gene promoter in Parkinson’s disease patients. Int. J. Neurosci. 121, 497-502. doi: 10.3109/00207454.2011.580866
15. Cai, Y., Liu, S., Sothern, R. B., Xu, S., and Chan, P. (2010). Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson’s disease. Eur. J. Neurol. 17, 550-554. doi: 10.1111/j.1468-1331.2009.02848.x
16. Carter, T. C., Pangilinan, F., Troendle, J. F., Molloy, A. M., Vandermeer, J., Mitchell, A., et al. (2011). Evaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study population. Am. J. Med. Genet. A 155A, 14-21. doi: 10.1002/ajmg.a.33755
17. Chartier-Harlin, M. C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., et al. (2004). Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 364, 1167-1169. doi: 10.1016/S0140-6736(04)17103-1
18. Cheon, S. M., Chan, L., Chan, D. K., and Kim, J. W. (2012). Genetics of Parkinson’s disease-a clinical perspective. J. Mov. Disord. 5, 33-41. doi: 10.14802/jmd. 12009
19. Christensen, B. C., Houseman, E. A., Marsit, C. J., Zheng, S., Wrensch, M. R., Wiemels, J. L., et al. (2009). Aging and environmental exposures alter tissuespecific DNA methylation dependent upon CpG island context. PLoS Genet. 5:e1000602. doi: 10.1371/journal.pgen.1000602
20. Chuang, Y. H., Quach, A., Absher, D., Assimes, T., Horvath, S., and Ritz, B. (2017). Coffee consumption is associated withDNA methylation levels of human blood. Eur. J. Hum. Genet. 25, 608-616. doi: 10.1038/ejhg.2016.175
21. Collin, S. M., Metcalfe, C., Zuccolo, L., Lewis, S. J., Chen, L., Cox, A., et al. (2009). Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 18, 2528-2539. doi: 10.1158/1055-9965.EPI-09-0223
22. Condliffe, D., Wong, A., Troakes, C., Proitsi, P., Patel, Y., Chouliaras, L., et al. (2014). Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer’s disease brain. Neurobiol. Aging 35, 1850-1854. doi: 10.1016/j.neurobiolaging. 2014.02.002
23. Coppede, F. (2012). Genetics and epigenetics of Parkinson’s disease. Sci. World J. 2012:489830. doi: 10.1100/2012/489830
24. Coppieters, N., Dieriks, B. V., Lill, C., Faull, R. L., Curtis, M. A., and Dragunow, M. (2014). Global changes in DNA methylation and hydroxymethylation in Alzheimer’s disease human brain. Neurobiol. Aging 35, 1334-1344. doi: 10.1016/j.neurobiolaging.2013. 11.031
25. Costa, J., Lunet, N., Santos, C., Santos, J., and Vaz-Carneiro, A. (2010). Caffeine exposure and the risk of Parkinson’s disease: a systematic review and metaanalysis of observational studies. J. Alzheimers Dis. 20(Suppl 1), S221-S238. doi: 10.3233/JAD-2010-091525
26. Coupland, K. G., Mellick, G. D., Silburn, P. A., Mather, K., Armstrong, N. J., Sachdev, P. S., et al. (2014). DNA methylation of the MAPT gene in Parkinson’s disease cohorts and modulation by vitamin E in vitro. Mov. Disord. 29, 1606-1614. doi: 10.1002/mds.25784
27. Cronin, K. D., Ge, D., Manninger, P., Linnertz, C., Rossoshek, A., Orrison, B. M., et al. (2009). Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain. Hum. Mol. Genet. 18, 3274-3285. doi: 10.1093/hmg/ddp265
28. Curtin, K., Slattery, M. L., Ulrich, C. M., Bigler, J., Levin, T. R., Wolff, R. K., et al. (2007). Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28, 1672-1679. doi: 10.1093/carcin/bgm089
29. Day, K., Waite, L. L., Thalacker-Mercer, A., West, A., Bamman, M. M., Brooks, J. D., et al. (2013). Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape. Genome Biol. 14:R102. doi: 10.1186/gb-2013-14-9-r102
30. de Boni, L., Tierling, S., Roeber, S., Walter, J., Giese, A., and Kretzschmar, H. A. (2011). Next-generation sequencing reveals regional differences of the alphasynuclein methylation state independent of Lewy body disease. Neuromol. Med. 13, 310-320. doi: 10.1007/s12017-011-8163-9
31. de Lau, L. M., Koudstaal, P. J., Van Meurs, J. B., Uitterlinden, A. G., Hofman, A., and Breteler, M. M. (2005). Methylenetetrahydrofolate reductase C677T genotype and PD. Ann. Neurol. 57, 927-930. doi: 10.1002/ana.20509
32. De Mena, L., Cardo, L. F., Coto, E., and Alvarez, V. (2013). No differential DNA methylation of PARK2 in brain of Parkinson’s disease patients and healthy controls. Mov. Disord. 28, 2032-2033. doi: 10.1002/mds.25593
33. Delamarre, A., and Meissner, W. G. (2017). Epidemiology, environmental risk factors and genetics of Parkinson’s disease. Presse Med. 46, 175-181. doi: 10.1016/j.lpm.2017.01.001
34. Desplats, P., Spencer, B., Coffee, E., Patel, P., Michael, S., Patrick, C., et al. (2011). Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J. Biol. Chem. 286, 9031-9037. doi: 10.1074/jbc.C110.212589
35. Domcke, S., Bardet, A. F., Adrian Ginno, P., Hartl, D., Burger, L., and Schubeler, D. (2015). Competition between DNA methylation and transcription factors determines binding of NRF1. Nature 528, 575-579. doi: 10.1038/nature16462
36. Edwards, J. R., O’donnell, A. H., Rollins, R. A., Peckham, H. E., Lee, C., Milekic, M. H., et al. (2010). Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res. 20, 972-980. doi: 10.1101/gr.1015 35.109
37. Ehrlich, M., and Wang, R. Y. (1981). 5-Methylcytosine in eukaryotic DNA. Science 212, 1350-1357. doi: 10.1126/science.6262918
38. Farooqui, T., and Farooqui, A. A. (2011). Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson’s disease. Parkinsons Dis. 2011:247467. doi: 10.4061/2011/247467
39. Fisk Green, R., Byrne, J., Crider, K. S., Gallagher, M., Koontz, D., and Berry, R. J. (2013). Folate-related gene variants in Irish families affected by neural tube defects. Front. Genet. 4:223. doi: 10.3389/fgene.2013.00223
40. Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., et al. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A. 102, 10604-10609. doi: 10.1073/pnas.0500398102
41. Frucht, S. J. (2004). Parkinson disease: an update. Neurologist 10, 185-194. doi: 10.1097/01.nrl.0000131146.08278.a5
42. Funahashi, Y., Yoshino, Y., Yamazaki, K., Mori, Y., Mori, T., Ozaki, Y., et al. (2017). DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies. Psychiatry Clin. Neurosci. 71, 28-35. doi: 10.1111/pcn.12462
43. Gibbs, J. R., Van Der Brug, M. P., Hernandez, D. G., Traynor, B. J., Nalls, M. A., Lai, S. L., et al. (2010). Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 6:e1000952. doi: 10.1371/journal.pgen.10 00952
44. Gibson, T. M., Brennan, P., Han, S., Karami, S., Zaridze, D., Janout, V., et al. (2011). Comprehensive evaluation of one-carbon metabolism pathway gene variants and renal cell cancer risk. PLoS ONE 6:e26165. doi: 10.1371/journal. pone.0026165
45. Gorgone, G., Curro, M., Ferlazzo, N., Parisi, G., Parnetti, L., Belcastro, V., et al. (2012). Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson’s disease patients. Neuromolecular Med. 14, 84-90. doi: 10.1007/s12017-012-8174-1
46. Gueant-Rodriguez, R. M., Gueant, J. L., Debard, R., Thirion, S., Hong, L. X., Bronowicki, J. P., et al. (2006). Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African and European populations. Am. J. Clin. Nutr. 83, 701-707.
47. Guhathakurta, S., Evangelista, B. A., Ghosh, S., Basu, S., and Kim, Y. S. (2017). Hypomethylation of intron1 of alpha-synuclein gene does not correlate with Parkinson’s disease. Mol. Brain 10:6. doi: 10.1186/s13041-017-0285-z
48. Guo, J. U., Su, Y., Shin, J. H., Shin, J., Li, H., Xie, B., et al. (2014). Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat. Neurosci. 17, 215-222. doi: 10.1038/nn.3607
49. Hahn, M. A., Qiu, R., Wu, X., Li, A. X., Zhang, H., Wang, J., et al. (2013). Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. Cell Rep. 3, 291-300. doi: 10.1016/j.celrep.2013.01.011
50. Hazra, A., Kraft, P., Lazarus, R., Chen, C., Chanock, S. J., Jacques, P., et al. (2009). Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum. Mol. Genet. 18, 4677-4687. doi: 10.1093/hmg/ddp428
51. He, Y. F., Li, B. Z., Li, Z., Liu, P., Wang, Y., Tang, Q., et al. (2011). Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303-1307. doi: 10.1126/science.1210944
52. Heyn, H., Li, N., Ferreira, H. J., Moran, S., Pisano, D. G., Gomez, A., et al. (2012). Distinct DNA methylomes of newborns and centenarians. Proc. Natl. Acad. Sci. U.S.A. 109, 10522-10527. doi: 10.1073/pnas.1120658109
53. Horvath, S. (2013). DNA methylation age of human tissues and cell types. Genome Biol. 14:R115. doi: 10.1186/gb-2013-14-10-r115
54. Hsieh, C. L. (1994). Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol. 14, 5487-5494. doi: 10.1128/MCB.14.8.5487
55. Iacono, D., Geraci-Erck, M., Rabin, M. L., Adler, C. H., Serrano, G., Beach, T. G., et al. (2015). Parkinson disease and incidental Lewy body disease: just a question of time? Neurology 85, 1670-1679. doi: 10.1212/WNL.0000000000002102
56. International Parkinson’s Disease Genomics Consortium (IPDGC) and Wellcome Trust Case Control Consortium 2 (WTCCC2) (2011). A two-stage metaanalysis identifies several new loci for Parkinson’s disease. PLoS Genet. 7:e1002142. doi: 10.1371/journal.pgen.1002142
57. Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., et al. (2009). The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178-186. doi: 10.1038/ng.298
58. Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., et al. (2011). Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300-1303. doi: 10.1126/science.1210597
59. Janezic, S., Threlfell, S., Dodson, P. D., Dowie, M. J., Taylor, T. N., Potgieter, D., et al. (2013). Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc. Natl. Acad. Sci. U.S.A. 110, E4016-E4025. doi: 10.1073/pnas.1309143110
60. Jang, B., Ishigami, A., Maruyama, N., Carp, R. I., Kim, Y. S., and Choi, E. K. (2013). Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration. Prion 7, 42-46. doi: 10.4161/pri.22380
61. Jones, P. A., and Liang, G. (2009). Rethinking how DNA methylation patterns are maintained. Nat. Rev. Genet. 10, 805-811. doi: 10.1038/nrg2651
62. Jowaed, A., Schmitt, I., Kaut, O., and Wullner, U. (2010). Methylation regulates alpha-synuclein expression and is decreased in Parkinson’s disease patients’ brains. J. Neurosci. 30, 6355-6359. doi: 10.1523/JNEUROSCI.6119-09.2010
63. Jung, H. J., Byun, H. O., Jee, B. A., Min, S., Jeoun, U. W., Lee, Y. K., et al. (2017). The Ubiquitin-like with PHD and ring finger domains 1 (UHRF1)/DNA methyltransferase 1 (DNMT1) axis is a primary regulator of cell senescence. J. Biol. Chem. 292, 3729-3739. doi: 10.1074/jbc.M116.750539
64. Jung, M., and Pfeifer, G. P. (2015). Aging and DNA methylation. BMC Biol. 13:7. doi: 10.1186/s12915-015-0118-4
65. Kaas, G. A., Zhong, C., Eason, D. E., Ross, D. L., Vachhani, R. V., Ming, G. L., et al. (2013). TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron 79, 1086-1093. doi: 10.1016/j.neuron.2013.08.032
66. Kajta, M., and Wojtowicz, A. K. (2013). Impact of endocrine-disrupting chemicals on neural development and the onset of neurological disorders. Pharmacol. Rep. 65, 1632-1639. doi: 10.1016/S1734-1140(13)71524-X
67. Kasowski, M., Grubert, F., Heffelfinger, C., Hariharan, M., Asabere, A., Waszak, S. M., et al. (2010). Variation in transcription factor binding among humans. Science 328, 232-235. doi: 10.1126/science.1183621
68. Kaut, O., Schmitt, I., and Wullner, U. (2012). Genome-scale methylation analysis of Parkinson’s disease patients’ brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics 13, 87-91. doi: 10.1007/s10048-011-0308-3
69. Kinde, B., Gabel, H. W., Gilbert, C. S., Griffith, E. C., and Greenberg, M. E. (2015). Reading the unique DNA methylation landscape of the brain: non-CpG methylation, hydroxymethylation, and MeCP2. Proc. Natl. Acad. Sci. U.S.A. 112, 6800-6806. doi: 10.1073/pnas.1411269112
70. Klose, R. J., and Bird, A. P. (2006). Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31, 89-97. doi: 10.1016/j.tibs.2005.12.008
71. Kohli, R. M., and Zhang, Y. (2013). TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502, 472-479. doi: 10.1038/nature12750
72. Kolahdouzan, M., and Hamadeh, M. J. (2017). The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci. Ther. 23, 272-290. doi: 10.1111/cns.12684
73. Kumar, D., and Thakur, M. K. (2017). Effect of perinatal exposure to Bisphenol-A on DNA methylation and histone acetylation in cerebral cortex and hippocampus of postnatal male mice. J. Toxicol. Sci. 42, 281-289. doi: 10.2131/jts.42.281
74. Kurdyukov, S., and Bullock, M. (2016). DNA methylation analysis: choosing the right method. Biology 5:E3. doi: 10.3390/biology5010003
75. Kwok, J. B., Teber, E. T., Loy, C., Hallupp, M., Nicholson, G., Mellick, G. D., et al. (2004). Tau haplotypes regulate transcription and are associated with Parkinson’s disease. Ann. Neurol. 55, 329-334. doi: 10.1002/ana.10826
76. Levine, A. J., Lee, W., Figueiredo, J. C., Conti, D. V., Vandenberg, D. J., Davis, B. D., et al. (2011). Variation in folate pathway genes and distal colorectal adenoma risk: a sigmoidoscopy-based case-control study. Cancer Causes Control 22, 541-552. doi: 10.1007/s10552-011-9726-7
77. Liang, S., Zhou, Y., Wang, H., Qian, Y., Ma, D., Tian, W., et al. (2014). The effect of multiple single nucleotide polymorphisms in the folic acid pathway genes on homocysteine metabolism. Biomed Res. Int. 2014:560183. doi: 10.1155/2014/560183
78. Lin, Q., Ding, H., Zheng, Z., Gu, Z., Ma, J., Chen, L., et al. (2012). Promoter methylation analysis of seven clock genes in Parkinson’s disease. Neurosci. Lett. 507, 147-150. doi: 10.1016/j.neulet.2011.12.007
79. Lister, R., Mukamel, E. A., Nery, J. R., Urich, M., Puddifoot, C. A., Johnson, N. D., et al. (2013). Global epigenomic reconfiguration during mammalian brain development. Science 341:1237905. doi: 10.1126/science.1237905
80. Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., et al. (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322. doi: 10.1038/nature08514
81. Liu, J., Qi, J., Yu, X., Zhu, J., Zhang, L., Ning, Q., et al. (2014). Investigations of single nucleotide polymorphisms in folate pathway genes in Chinese families with neural tube defects. J. Neurol. Sci. 337, 61-66. doi: 10.1016/j.jns.2013. 11.017
82. Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M., and Kroemer, G. (2013). The hallmarks of aging. Cell 153, 1194-1217. doi: 10.1016/j.cell.2013.05.039
83. Maegawa, S., Hinkal, G., Kim, H. S., Shen, L., Zhang, L., Zhang, J., et al. (2010). Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res. 20, 332-340. doi: 10.1101/gr.096826.109
84. Manjegowda, M. C., Gupta, P. S., and Limaye, A. M. (2017). Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells. Gene 614, 65-73. doi: 10.1016/j.gene.2017.03.006
85. Maraganore, D. M., De Andrade, M., Elbaz, A., Farrer, M. J., Ioannidis, J. P., Kruger, R., et al. (2006). Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296, 661-670. doi: 10.1001/jama.296.6.661
86. Maroteaux, L., Campanelli, J. T., and Scheller, R. H. (1988). Synuclein: a neuronspecific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
87. Masliah, E., Dumaop, W., Galasko, D., and Desplats, P. (2013). Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 8, 1030-1038. doi: 10.4161/epi.25865
88. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., et al. (2000). Dopaminergic loss and inclusion body formation in alphasynuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269. doi: 10.1126/science.287.5456.1265
89. Mastronardi, F. G., Noor, A., Wood, D. D., Paton, T., and Moscarello, M. A. (2007). Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J. Neurosci. Res. 85, 2006-2016. doi: 10.1002/jnr.21329
90. Matsumoto, L., Takuma, H., Tamaoka, A., Kurisaki, H., Date, H., Tsuji, S., et al. (2010). CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson’s disease. PLoS ONE 5:e15522. doi: 10.1371/journal. pone.0015522
91. Mellen, M., Ayata, P., Dewell, S., Kriaucionis, S., and Heintz, N. (2012). MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417-1430. doi: 10.1016/j.cell.2012.11.022
92. Metayer, C., Scelo, G., Chokkalingam, A. P., Barcellos, L. F., Aldrich, M. C., Chang, J. S., et al. (2011). Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 22, 1243-1258. doi: 10.1007/s10552-011-9795-7
93. Moore, K., Mcknight, A. J., Craig, D., and O’neill, F. (2014). Epigenome-wide association study for Parkinson’s disease. Neuromolecular Med. 16, 845-855. doi: 10.1007/s12017-014-8332-8
94. Nalls, M. A., Pankratz, N., Lill, C. M., Do, C. B., Hernandez, D. G., Saad, M., et al. (2014). Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat. Genet. 46, 989-993. doi: 10.1038/ng. 3043
95. Nalls, M. A., Plagnol, V., Hernandez, D. G., Sharma, M., Sheerin, U. M., Saad, M., et al. (2011). Imputation of sequence variants for identification of genetic risks for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet 377, 641-649. doi: 10.1016/S0140-6736(10)62345-8
96. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., et al. (1998). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389. doi: 10.1038/30764
97. Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., et al. (1999). Both familial Parkinson’s disease mutations accelerate alpha-synuclein aggregation. J. Biol. Chem. 274, 9843-9846. doi: 10.1074/jbc.274.14.9843
98. Nicholas, A. P. (2011). Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra. Neurosci. Lett. 495, 26-29. doi: 10.1016/j. neulet.2011.03.028
99. Obeid, R., Schadt, A., Dillmann, U., Kostopoulos, P., Fassbender, K., and Herrmann, W. (2009). Methylation status and neurodegenerative markers in Parkinson disease. Clin. Chem. 55, 1852-1860. doi: 10.1373/clinchem.2009. 125021
100. Ohm, J. E., Mcgarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., et al. (2007). A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39, 237-242. doi: 10.1038/ng1972
101. Ouyang, S., Li, Y., Liu, Z., Chang, H., and Wu, J. (2013). Association between MTR A2756G and MTRR A66G polymorphisms and maternal risk for neural tube defects: a meta-analysis. Gene 515, 308-312. doi: 10.1016/j.gene.2012.11.070
102. Park, J. Y., and Lansbury, P. T. Jr. (2003). Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson’s disease. Biochemistry 42, 3696-3700. doi: 10.1021/bi020604a
103. Pastor, W. A., Aravind, L., and Rao, A. (2013). TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 14, 341-356. doi: 10.1038/nrm3589
104. Pieper, H. C., Evert, B. O., Kaut, O., Riederer, P. F., Waha, A., and Wullner, U. (2008). Different methylation of the TNF-alpha promoter in cortex and substantia nigra: implications for selective neuronal vulnerability. Neurobiol. Dis. 32, 521-527. doi: 10.1016/j.nbd.2008.09.010
105. Pihlstrom, L., Berge, V., Rengmark, A., and Toft, M. (2015). Parkinson’s disease correlates with promoter methylation in the alpha-synuclein gene. Mov. Disord. 30, 577-580. doi: 10.1002/mds.26073
106. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045-2047. doi: 10.1126/science.276.5321.2045
107. Preciados, M., Yoo, C., and Roy, D. (2016). Estrogenic endocrine disrupting chemicals influencing NRF1 regulated gene networks in the development of complex human brain diseases. Int. J. Mol. Sci. 17:E2086. doi: 10.3390/ijms17122086
108. Rakyan, V. K., Down, T. A., Maslau, S., Andrew, T., Yang, T. P., Beyan, H., et al. (2010). Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res. 20, 434-439. doi: 10.1101/gr. 103101.109
109. Refenes, N., Bolbrinker, J., Tagaris, G., Orlacchio, A., Drakoulis, N., and Kreutz, R. (2009). Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson’s disease. BMC Neurol. 9:26. doi: 10.1186/1471-2377-9-26
110. Richter, J., Appenzeller, S., Ammerpohl, O., Deuschl, G., Paschen, S., Bruggemann, N., et al. (2012). No evidence for differential methylation of alpha-synuclein in leukocyte DNA of Parkinson’s disease patients. Mov. Disord. 27, 590-591. doi: 10.1002/mds.24907
111. Rozen, R. (1997). Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb. Haemost. 78, 523-526.
112. Schmitt, I., Kaut, O., Khazneh, H., Deboni, L., Ahmad, A., Berg, D., et al. (2015). L-dopa increases alpha-synuclein DNA methylation in Parkinson’s disease patients in vivo and in vitro. Mov. Disord. 30, 1794-1801. doi: 10.1002/mds. 26319
113. Searles Nielsen, S., Checkoway, H., Criswell, S. R., Farin, F. M., Stapleton, P. L., Sheppard, L., et al. (2015). Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders. Parkinsonism Relat. Disord. 21, 355-360. doi: 10.1016/j.parkreldis.2015.01.007
114. Sharma, M., Ioannidis, J. P., Aasly, J. O., Annesi, G., Brice, A., Van Broeckhoven, C., et al. (2012). Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 79, 659-667. doi: 10.1212/WNL.0b013e318264e353
115. Shin, W., Yan, J., Abratte, C. M., Vermeylen, F., and Caudill, M. A. (2010). Choline intake exceeding current dietary recommendations preserves markers of cellular methylation in a genetic subgroup of folate-compromised men. J. Nutr. 140, 975-980. doi: 10.3945/jn.110.121186
116. Siegfried, Z., Eden, S., Mendelsohn, M., Feng, X., Tsuberi, B. Z., and Cedar, H. (1999). DNA methylation represses transcription in vivo. Nat. Genet. 22, 203-206. doi: 10.1038/9727
117. Simon-Sanchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., et al. (2009). Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat. Genet. 41, 1308-1312. doi: 10.1038/ng.487
118. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., et al. (2003). alpha-Synuclein locus triplication causes Parkinson’s disease. Science 302, 841.
119. Skvortsova, K., Zotenko, E., Luu, P. L., Gould, C. M., Nair, S. S., Clark, S. J., et al. (2017). Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA. Epigenetics Chromatin 10:16. doi: 10.1186/s13072-017-0123-7
120. Sokratous, M., Dardiotis, E., Tsouris, Z., Bellou, E., Michalopoulou, A., Siokas, V., et al. (2016). Deciphering the role of DNA methylation in multiple sclerosis: emerging issues. Auto Immun. Highlights 7:12. doi: 10.1007/s13317-016-0084-z
121. Soldner, F., Stelzer, Y., Shivalila, C. S., Abraham, B. J., Latourelle, J. C., Barrasa, M. I., et al. (2016). Parkinson-associated risk variant in distal enhancer of alphasynuclein modulates target gene expression. Nature 533, 95-99. doi: 10.1038/nature17939
122. Song, Y., Ding, H., Yang, J., Lin, Q., Xue, J., Zhang, Y., et al. (2014). Pyrosequencing analysis of SNCA methylation levels in leukocytes from Parkinson’s disease patients. Neurosci. Lett. 569, 85-88. doi: 10.1016/j.neulet.2014.03.076
123. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997). Alpha-synuclein in Lewy bodies. Nature 388, 839-840. doi: 10.1038/42166
124. Steegers-Theunissen, R. P., Obermann-Borst, S. A., Kremer, D., Lindemans, J., Siebel, C., Steegers, E. A., et al. (2009). Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS ONE 4:e7845. doi: 10.1371/journal.pone.00 07845
125. Stöger, R., Scaife, P. J., Shephard, F., and Chakrabarti, L. (2017). Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease. npj Parkinsons Disease 3, 6. doi: 10.1038/s41531-017-0007-3
126. Su, X., Chu, Y., Kordower, J. H., Li, B., Cao, H., Huang, L., et al. (2015). PGC-1a promoter methylation in Parkinson’s disease. PLoS ONE 10:e0134087. doi: 10.1371/journal.pone.0134087
127. Szulwach, K. E., Li, X., Li, Y., Song, C. X., Wu, H., Dai, Q., et al. (2011). 5-hmCmediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci. 14, 1607-1616. doi: 10.1038/nn.2959
128. Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., et al. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935. doi: 10.1126/science.1170116
129. Takai, D., and Jones, P. A. (2002). Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. U.S.A. 99, 3740-3745. doi: 10.1073/pnas.052410099
130. Tan, Q., Heijmans, B. T., Hjelmborg, J. V., Soerensen, M., Christensen, K., and Christiansen, L. (2016). Epigenetic drift in the aging genome: a ten-year followup in an elderly twin cohort. Int. J. Epidemiol. 45, 1146-1158. doi: 10.1093/ije/dyw132
131. Tan, Y., Wu, L., Li, D., Liu, X., Ding, J., and Chen, S. (2016). Methylation status of DJ-1 in leukocyte DNA of Parkinson’s disease patients. Transl. Neurodegener. 5:5. doi: 10.1186/s40035-016-0052-6
132. Tanaka, T., Scheet, P., Giusti, B., Bandinelli, S., Piras, M. G., Usala, G., et al. (2009). Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am. J. Hum. Genet. 84, 477-482. doi: 10.1016/j.ajhg.2009.02.011
133. Tarale, P., Sivanesan, S., Daiwile, A. P., Stoger, R., Bafana, A., Naoghare, P. K., et al. (2016). Global DNA methylation profiling of manganese-exposed human neuroblastoma SH-SY5Y cells reveals epigenetic alterations in Parkinson’s disease-associated genes. Arch. Toxicol. 91, 2629-2641. doi: 10.1007/s00204-016-1899-0
134. Tobi, E. W., Lumey, L. H., Talens, R. P., Kremer, D., Putter, H., Stein, A. D., et al. (2009). DNA methylation differences after exposure to prenatal famine are common and timing-and sex-specific. Hum. Mol. Genet. 18, 4046-4053. doi: 10.1093/hmg/ddp353
135. Turner, B. M. (2007). Defining an epigenetic code. Nat. Cell Biol. 9, 2-6. doi: 10.1038/ncb0107-2
136. Varley, K. E., Gertz, J., Bowling, K. M., Parker, S. L., Reddy, T. E., Pauli-Behn, F., et al. (2013). Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res. 23, 555-567. doi: 10.1101/gr.147942.112
137. Vigneswara, V., Cass, S., Wayne, D., Bolt, E. L., Ray, D. E., and Carter, W. G. (2013). Molecular ageing of alpha-and Beta-synucleins: protein damage and repair mechanisms. PLoS ONE 8:e61442. doi: 10.1371/journal.pone.0061442
138. Villar-Menendez, I., Blanch, M., Tyebji, S., Pereira-Veiga, T., Albasanz, J. L., Martin, M., et al. (2013). Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington’s disease. Neuromolecular Med. 15, 295-309. doi: 10.1007/s12017-013-8219-0
139. Wang, F., Yang, Y., Lin, X., Wang, J. Q., Wu, Y. S., Xie, W., et al. (2013). Genomewide loss of 5-hmC is a novel epigenetic feature of Huntington’s disease. Hum. Mol. Genet. 22, 3641-3653. doi: 10.1093/hmg/ddt214
140. Waterland, R. A., Dolinoy, D. C., Lin, J. R., Smith, C. A., Shi, X., and Tahiliani, K. G. (2006). Maternal methyl supplements increase offspring DNA methylation at Axin Fused. Genesis 44, 401-406. doi: 10.1002/dvg.20230
141. Waterland, R. A., and Jirtle, R. L. (2003). Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 23, 5293-5300. doi: 10.1128/MCB.23.15.5293-5300.2003
142. Wei, Y., Yang, N., Xu, Q., Sun, Q., Guo, J., Li, K., et al. (2016). The rs3756063 polymorphism is associated with SNCA methylation in the Chinese Han population. J. Neurol. Sci. 367, 11-14. doi: 10.1016/j.jns.2016.05.037
143. Weidner, C. I., Lin, Q., Koch, C. M., Eisele, L., Beier, F., Ziegler, P., et al. (2014). Aging of blood can be tracked by DNA methylation changes at just three CpG sites. Genome Biol. 15:R24. doi: 10.1186/gb-2014-15-2-r24
144. Weiner, A. S., Boyarskikh, U. A., Voronina, E. N., Selezneva, I. A., Sinkina, T. V., Lazarev, A. F., et al. (2012). Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk. Cancer Epidemiol. 36, e95-e100. doi: 10.1016/j.canep.2011.11.010
145. Wernimont, S. M., Clark, A. G., Stover, P. J., Wells, M. T., Litonjua, A. A., Weiss, S. T., et al. (2011). Folate network genetic variation, plasma homocysteine, and global genomic methylation content: a genetic association study. BMC Med. Genet. 12:150. doi: 10.1186/1471-2350-12-150
146. Wilcken, B., Bamforth, F., Li, Z., Zhu, H., Ritvanen, A., Renlund, M., et al. (2003). Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J. Med. Genet. 40, 619-625. doi: 10.1136/jmg.40.8.619
147. Willis, A. W., Evanoff, B. A., Lian, M., Galarza, A., Wegrzyn, A., Schootman, M., et al. (2010a). Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. Am. J. Epidemiol. 172, 1357-1363. doi: 10.1093/aje/kwq303
148. Willis, A. W., Sterling, C., and Racette, B. A. (2010b). Conjugal Parkinsonism and Parkinson disease: a case series with environmental risk factor analysis. Parkinsonism Relat. Disord. 16, 163-166. doi: 10.1016/j.parkreldis.2009.09.002
149. Wnuk, A., Rzemieniec, J., Litwa, E., Lason, W., Krzeptowski, W., Wojtowicz, A. K., et al. (2016). The crucial involvement of retinoid X receptors in DDE neurotoxicity. Neurotox. Res. 29, 155-172. doi: 10.1007/s12640-015-9572-6
150. Wu, H., Caffo, B., Jaffee, H. A., Irizarry, R. A., and Feinberg, A. P. (2010). Redefining CpG islands using hiddenMarkov models. Biostatistics 11, 499-514. doi: 10.1093/biostatistics/kxq005
151. Wu, X., Wang, X., Chan, Y., Jia, S., Luo, Y., and Tang, W. (2013). Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for Down syndrome offspring: a meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 167, 154-159. doi: 10.1016/j.ejogrb.2012. 11.022
152. Yang, N., Wei, Y., Wang, T., Guo, J., Sun, Q., Hu, Y., et al. (2016). Genome-wide analysis of DNA methylation during antagonism of DMOG to MnCl2-induced cytotoxicity in the mouse substantia nigra. Sci. Rep. 6:28933. doi: 10.1038/srep28933
153. Yao, B., Christian, K. M., He, C., Jin, P., Ming, G. L., and Song, H. (2016). Epigenetic mechanisms in neurogenesis. Nat. Rev. Neurosci. 17, 537-549. doi: 10.1038/nrn. 2016.70
154. Yoshino, Y., Mori, T., Yoshida, T., Yamazaki, K., Ozaki, Y., Sao, T., et al. (2016). Elevated mRNA expression and low methylation of SNCA in Japanese Alzheimer’s disease subjects. J. Alzheimers Dis. 54, 1349-1357. doi: 10.3233/JAD-160430
155. Yuan, L., Song, Z., Deng, X., Xiong, W., Yang, Z., and Deng, H. (2016). Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson’s disease patients. Neurosci. Lett. 616, 26-31. doi: 10.1016/j.neulet.2016. 01.031
156. Zabetian, C. P., Hutter, C. M., Factor, S. A., Nutt, J. G., Higgins, D. S., Griffith, A., et al. (2007). Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson’s disease. Ann. Neurol. 62, 137-144. doi: 10.1002/ana.21157
157. Zhang, D., Cheng, L., Badner, J. A., Chen, C., Chen, Q., Luo, W., et al. (2010). Genetic control of individual differences in gene-specific methylation in human brain. Am. J. Hum. Genet. 86, 411-419. doi: 10.1016/j.ajhg.2010.02.005
158. Zhu, Y., Zhu, R. X., He, Z. Y., Liu, X., and Liu, H. N. (2015). Association of MTHFR C677T with total homocysteine plasma levels and susceptibility to Parkinson’s disease: a meta-analysis. Neurol. Sci. 36, 945-951. doi: 10.1007/s10072-014-2052-6